BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8931119)

  • 41. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone.
    Olsen NV; Jensen NG; Hansen JM; Christensen NJ; Fogh-Andersen N; Kanstrup IL
    Clin Sci (Lond); 1999 Oct; 97(4):457-65. PubMed ID: 10491346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.
    Bannwarth B
    Drug Saf; 2008; 31(6):485-503. PubMed ID: 18484783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
    Kim JH; Rhee HI; Jung IH; Ryu K; Jung K; Han CK; Kwak WJ; Cho YB; Joo HJ
    Life Sci; 2005 Jul; 77(11):1181-93. PubMed ID: 15935401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of non-steroidal anti-inflammatory drugs on neutrophil chemotaxis--an in vitro and in vivo study.
    Ip M; Lomas DA; Shaw J; Burnett D; Stockley RA
    Br J Rheumatol; 1990 Oct; 29(5):363-7. PubMed ID: 2224405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
    Boyle EA; Freeman PC; Mangan FR; Thomson MJ
    J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphonuclear leukocytes activation: in vitro modulation by 6-methoxy-2-naphthylacetic acid, the major active metabolite of nabumetone.
    Allegrezza-Giulietti A; Serretti R; Peroni M; Cervini C
    Pharmacol Res; 1993 Sep; 28(2):163-73. PubMed ID: 8278307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of apoptotic DNA fragmentation by nonsteroidal anti-inflammatory drugs in cultured rat gastric mucosal cells.
    Kusuhara H; Matsuyuki H; Matsuura M; Imayoshi T; Okumoto T; Matsui H
    Eur J Pharmacol; 1998 Nov; 360(2-3):273-80. PubMed ID: 9851595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effects of nabumetone, naproxen, piroxicam, and diclofenac on rat gastric irritancy following acute exposure to OTC non-steroidal anti-inflammatory agents and other gastric irritants.
    Carryl OR; Spangler RS
    Scand J Rheumatol; 1995; 24(6):336-41. PubMed ID: 8610216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of n-3 polyunsaturated fatty acids on indomethacin-induced changes in eicosanoid production and blood flow in the gastric mucosa of rats.
    Shimizu T; Suzuki M; Lee T; Igarashi J; Kaneko K; Yamashiro Y
    Prostaglandins Leukot Essent Fatty Acids; 2003 Jul; 69(1):33-7. PubMed ID: 12878448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Marshall PJ; Griswold DE; Breton J; Webb EF; Hillegass LM; Sarau HM; Newton J; Lee JC; Bender PE; Hanna N
    Biochem Pharmacol; 1991 Jul; 42(4):813-24. PubMed ID: 1907824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.
    Matsumoto K; Hasegawa T; Ohara K; Takei C; Kamei T; Koyanagi J; Takahashi T; Akimoto M
    Xenobiotica; 2020 Jul; 50(7):783-792. PubMed ID: 31855101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo.
    Kerola M; Vuolteenaho K; Kosonen O; Kankaanranta H; Sarna S; Moilanen E
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):17-21. PubMed ID: 19152549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
    Griswold DE; Marshall PJ; Lee JC; Webb EF; Hillegass LM; Wartell J; Newton J; Hanna N
    Biochem Pharmacol; 1991 Jul; 42(4):825-31. PubMed ID: 1907825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of lysine clonixinate and indomethacin on lipoxygenase and cyclooxygenase activity in colon isolated from cancer patients].
    Franchi A; Di Girolamo G; de los Santos AR; Marti ML; Gimeno MA
    Medicina (B Aires); 1998; 58(3):291-4. PubMed ID: 9713099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different modes of inhibition of rat gastric mucosal 6-keto-PGF1 alpha production by indomethacin, aspirin and aminopyrine.
    Nishikawa T; Tomori Y; Yamashita S; Shimizu S
    Jpn J Pharmacol; 1989 Apr; 49(4):483-9. PubMed ID: 2498559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers.
    Freed MI; Audet PR; Zariffa N; Krishna GG; Ilson BE; Everitt DE; Brown LE; Rizzo SM; Nichols AI; Jorkasky DK
    J Clin Pharmacol; 1994 Nov; 34(11):1098-108. PubMed ID: 7876402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid.
    Ogata K; Takamura N; Tokunaga J; Ikeda T; Setoguchi N; Tanda K; Yamasaki T; Nishio T; Kawai K
    Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):179-86. PubMed ID: 25537338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.